1. Home
  2. LFUS vs PODD Comparison

LFUS vs PODD Comparison

Compare LFUS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

N/A

Current Price

$417.64

Market Cap

11.7B

Sector

Energy

ML Signal

N/A

Logo Insulet Corporation

PODD

Insulet Corporation

N/A

Current Price

$147.56

Market Cap

10.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFUS
PODD
Founded
1927
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
10.3B
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
LFUS
PODD
Price
$417.64
$147.56
Analyst Decision
Strong Buy
Buy
Analyst Count
3
21
Target Price
$366.67
$341.48
AVG Volume (30 Days)
182.3K
1.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
2.96
2.67
Revenue
$757,853,000.00
$2,708,100,000.00
Revenue This Year
$14.65
$24.55
Revenue Next Year
$6.98
$19.18
P/E Ratio
$139.62
$56.08
Revenue Growth
N/A
30.73
52 Week Low
$233.36
$126.40
52 Week High
$500.57
$354.88

Technical Indicators

Market Signals
Indicator
LFUS
PODD
Relative Strength Index (RSI) 44.65 50.87
Support Level $386.67 $139.67
Resistance Level $426.44 $155.17
Average True Range (ATR) 15.42 5.28
MACD -1.89 0.94
Stochastic Oscillator 20.52 67.83

Price Performance

Historical Comparison
LFUS
PODD

About LFUS Littelfuse Inc.

Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: